• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Why Interoperability is Key to Successful Digital Pharma Solutions

Share:

July 3, 2023

Pharmaceutical companies are reevaluating their digital patient solutions and seeking more customized and interoperable platforms. When considering a technology partner, there are key questions to ask to ensure a worthwhile investment: their experience and integrations, flexibility, scalability, monitoring processes, and speed of implementation. A good technology partner can provide seamless integration, customization, regulatory compliance, and front-end benefits for patients such as simplified onboarding, improved communication, and personalized care. Partnering with the right technology partner can drive revenue, enhance patient engagement, and improve outcomes.

We are at an interesting crossroads when it comes to pharma and digital health. Several years after the first iteration of digital patient solutions was initially launched, many pharma companies are taking a step back to strategically evaluate how they have performed in practice and the impact they have had on both patient and business outcomes.

Unfortunately, many platforms that pharma companies have either integrated within existing platforms or built have failed to meet those needs – for instance, only about 3% of patients currently take advantage of digital solutions. One possible reason is that when pharma companies first developed solutions, many bought a pre-constructed platform with a generic infrastructure, or tried to build solutions on their own. This resulted in programs that were poorly integrated and too broad, ultimately creating a clunky user experience, among many other challenges like taking a long time to build, being non-compliant with regulatory standards, and overall functionality issues.

Many pharma companies are turning to vendors who can create more customized, personalized, and interoperable solutions to support patients throughout their medication journeys. As you reevaluate your current program and consider working with a partner, here are the five questions you should be asking to ensure your investment will be worth it.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

1. How many platforms/solutions have they built thus far?

Knowing the level of experience of your partner organization is key to understanding the value they bring to you. Asking how many customers they have worked with, in addition to how many integrations they have done, will give you insight into whether or not they can seamlessly work within your existing system and the technologies your team is already using.

2. Are they willing to be flexible?

Every pharma company has their own goals, and each therapeutic requires a different level of patient support. Working with a partner who understands these needs and can offer customizable solutions will be key to creating an effective platform.

3. How do they handle scalability?

The number of customers they have worked with is one thing, but understanding how they have been able to scale those programs is perhaps even more important. Can they provide examples of programs that they have scaled globally? You should also inquire about how many patients are coming into the backend of their system every day. If they are able to handle high and growing volumes of patients, you’ll get a good idea of whether or not you’ll be able to work with them in the long term.

4. How are they monitoring the integrations?

A bad user experience can completely destroy a digital program, so you want to work with a partner who is constantly checking for bugs and glitches – and catching them before the users. You should always ask what their monitoring process looks like, and how often they are doing it.

5. How fast can they get the integrations up and running?

Without the proper documentation, regulatory background, and infrastructure in place, it can take a long time – sometimes years – to develop a program. Working with a partner that can put a program together on time, not to mention on budget, is critical to a program’s success.

The value of good partner

In addition to the back-end benefits that a good technology partner can provide, like seamless integration, go-to-market efficiency, SaMD capabilities, customization, and meeting regulatory standards, there are also many benefits for the front-end user – the patient – too.

The first of which is that patients can get started in programs more easily and quickly. Getting patients to sign up for these programs in the first place can be a hurdle, so making the onboarding process simple is key to encouraging participation. Interoperable programs also allow for easier document sharing, speeding up the approval process for patients to get started in these programs. The quicker patients can get started, the more motivated they will be to participate.

Integrated programs also allow for more frequent and comprehensive communication between patients and support staff. This ensures all patient questions are answered and their needs are met, leading to better engagement and adherence, and ultimately healthier patients. Working with the right partner can help you greatly improve patient outcomes.

At the same time, support staff will have more insights into the patient’s behavior. They’ll know if a patient forgot to fill a prescription or missed a dose, enabling quicker interventions to help patients stay on track. This information can also be used by pharma companies and providers to provide more personalized care, and even guide future treatment plans for other patients.

Conclusion

Digital pharma solutions can be incredibly valuable resources for pharma companies, patients, and providers. Working with a highly experienced technology partner that can create a well-integrated program will be key to capitalizing on their value. Investment in a good partner will not only drive revenue, but it will also increase patient engagement, improve patient adherence (thus increasing Rx revenue), and can even provide a synergistic patient experience with patient support services or patient monitoring – ultimately contributing to improved patient outcomes. By asking these questions, you can ensure your investment will reap the benefits.

Source: HitConsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Vir Biotechnology and Biogen Execute Agreement to Manufacture SARS-CoV-2 Antibodies for Potential COVID-19 TreatmentVir Biotechnology and Biogen Execute Agreement to Manufacture SARS-CoV-2 Antibodies for Potential COVID-19 Treatment
  • Rheumatoid Arthritis Drugs Market: Use of Rheumatoid Arthritis Drugs in Treating COVID-19 May Serve As a Game-Changer for GrowthRheumatoid Arthritis Drugs Market: Use of Rheumatoid Arthritis Drugs in Treating COVID-19 May Serve As a Game-Changer for Growth
  • How Care Coordination Technology Addresses Social Isolation in SeniorsHow Care Coordination Technology Addresses Social Isolation in Seniors
  • Invitae to Acquire Singular Bio to Help Increase Access to Genetic Screening in Early PregnancyInvitae to Acquire Singular Bio to Help Increase Access to Genetic Screening in Early Pregnancy
  • John Hancock Taps Verily, Onduo for New Diabetes Management OfferingJohn Hancock Taps Verily, Onduo for New Diabetes Management Offering
  • BrightInsight Raises $40M in Series B Funding to Cement its Position as the Leading Global Regulated Digital Health Platform for Biopharma and MedtechBrightInsight Raises $40M in Series B Funding to Cement its Position as the Leading Global Regulated Digital Health Platform for Biopharma and Medtech
  • AI for Pharma and Biotech Market: Facts, Figures and Analytical Insights, 2020 to 2025AI for Pharma and Biotech Market: Facts, Figures and Analytical Insights, 2020 to 2025
  • XRHealth to Launch Virtual Reality Telehealth Clinic in Israel In NovemberXRHealth to Launch Virtual Reality Telehealth Clinic in Israel In November

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications